Latest developments and new challenges for Cancer patient in Intensive Care Unit
It has been believed for years that cancer patients have not been
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
It has been believed for years that cancer patients have not been
It has been believed for years that cancer patients have not been
drug release. Nanomedicines based on self-assembled peptide carrier systems have been developed in recent years for cancer targeting. Self-assembled peptides have tremendous properties of forming targeted drug delivery…
substantially cheaper and suitable for large populations of patients. We have helped with the development of allogeneic CAR T cells, now in a number of phase-I clinical trials, providing ... vaccination induced antigen…
All great Prophets (AS) are the chosen men of God (Allah). They
Treatment for life threatening diseases like cancer has been the most discussed
The selective delivery and effective localisation of drugs is crucial in cancer
given treatment (right drug for the right patient). This approach is utilized in cancer drug development as well as in measuring patient’s response to therapy. Targeted therapies are designed ... cell membrane and block…
HOXB3 in cervical cancer cells and their clinical values in the occurrence and development of cervical cancer, thus providing reliable basis for targeted therapy of cervical cancer. Methods: Cancer cell ... detects the…
1970s. Whilst the paradigm of cancer cells being sensitive to DNA damaging chemotherapy as a result of rapid growth and then developing chemotherapy resistance and hence avoiding being killed ... hypothesis. The new…
In an aging population, the decline in muscle mass and strength in
glycosphingolipid core structures during differentiation of human embryonic stem cells (hESCs) and development of glycan-targeted cancer vaccine cancer. First, we will describe a systematic survey of expression profiles…
childhood cancers compared with cancers in adults. The focus of new drug development for childhood cancers has shifted to molecularly targeted drugs that selectively inhibit cell-signaling pathways responsible
Breast cancer is an increasingly recognized public health concern in developing countries. The clinical spectrum is heterogeneous but largely characterized at presentation by a more advanced stage, the presence…
standard of care in some patients. Here we propose the development of an in situ autologous cancer vaccine, inCVAX, for the treatment of hepatocellular cancer (HCC). inCVAX is based ... induction of local immunogenic…
Evidences from cancer stem cell biology and the development of new models to validate the self renewal of stem cells are suggesting that stem cells are susceptive to carcinogenesis ... consequently can be the origin of…
overt infection. Recent studies have demonstrated that OBI patients have increased risk of developing HCC. By comparison between HCC cases arising from OBI patients and chronic HBV patients, HCC patients ... increased…
cells then they will burn them. The NP will circulate through the body, detect cancer associated molecular changes, assist with imaging, release a therapeutic agent and then monitor the effectiveness ... last two…
Cancer immunology has been an area of interest with the rise of novel approaches to specifically target a tumor with the aid of the body?s immune system. Many tumor ... recent past. However, since antigens are proteins…
vascular lesions occurs before the development of human AD, in animal models that mimic human neurodegeneration and human colorectal carcinoid cancer or malignant brain cancer. In situ hybridization and ultrastructural…
cancer-free controls and investigated the association between genetic variation in the promoter region of MDM2 (c.–51309G4T, rs2279744:g.G4T) and the risk of developing NSCLC by tetra-primer ARMS
treatment (right drug for the right patient). This approach should be utilized in cancer drug development as well as measuring patient?s response to therapy. Some examples of these targeted ... factor receptor…
The cellular immune system can potentially recognise and destroy cancers but there
A lthough small interfering RNA (siRNA) treatment holds great promise for the
For authors and organisers
Find the right journal for your paper and submit your manuscript.